This study suggests greater variability in the clinical spectrum of IOSCA than reported previously and that screening of C10orf2 may be helpful in diagnosing IOSCA, especially in patients presenting with symptoms of axonal sensorimotor polyneuropathy and myopathy. This evidence concerns the gene TWNK and myopathy.